👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

IMAX stock price target lifted, buy rating on growth prospects

EditorNatashya Angelica
Published 2024-12-13, 09:02 a/m
IMAX
-

On Friday, Benchmark upgraded its outlook on shares of IMAX Corporation (NYSE:IMAX), increasing the price target to $30.00 from the previous $22.00, while maintaining a Buy rating for the stock.

Moreover, IMAX has been included in the 'Best Ideas for 2025' list, highlighting the firm's optimism about the company's future performance. The upgrade comes as IMAX shows remarkable momentum, with InvestingPro data revealing a 72% year-to-date return and the stock trading near its 52-week high of $26.84.

The revised price target reflects a heightened confidence in IMAX's growth potential, driven by a strong pipeline of films, including both major Hollywood productions and popular local-language titles. The company's expanding network of theaters and considerable operating leverage also contribute to the positive outlook.

According to InvestingPro analysis, IMAX maintains a healthy financial position with a current ratio of 3.31 and operates with a moderate debt level, though it currently trades at elevated valuation multiples.

Benchmark's analysis anticipates IMAX's adjusted EBITDA for the fiscal year 2025 to reach $152 million. Applying a multiple of 12x to this forecast, the firm calculates an enterprise value (EV) of $1.826 billion, plus net cash, to support the new price target of $30. The firm reiterates its Buy rating on the stock based on these projections.

The inclusion of IMAX in the 'Best Ideas for 2025' list suggests that Benchmark sees the company as a top pick for investors looking ahead to the next few years. This endorsement is based on IMAX's strategic position in the entertainment industry and its ability to capitalize on the global demand for high-quality cinematic experiences.

InvestingPro subscribers can access 12 additional key insights about IMAX, including detailed analysis of its growth trajectory and market position in our comprehensive Pro Research Report.

IMAX's growth strategy appears to be well-received by Benchmark, as evidenced by the raised price target and sustained Buy rating. Investors and market watchers will likely monitor the company's performance closely to see if it can meet these expectations and realize its projected growth trajectory.

In other recent news, IMAX Corporation has been making significant strides in its financial performance. In its Q3 2024 earnings call, the company reported an adjusted EBITDA of $39 million, a 42% margin, and earnings per share (EPS) of $0.35, surpassing forecasts by over 50%. Revenue for the quarter was reported at $91.5 million, driven by major titles and content solutions.

In addition to these notable earnings results, B. Riley adjusted its outlook on IMAX Corporation, increasing the shares target from $30.00 to $33.00 while maintaining a Buy rating on the stock. This decision was based on a recent investor call with IMAX's top management, which provided deeper insights into the company's strategic position within the film industry.

Furthermore, IMAX has seen a significant increase in system installations and expects to end the year within the range of 130-150. The company also anticipates a global box office exceeding $1.2 billion in 2025, supported by a strong film slate. On the financial front, the company's capital position remains robust with $105 million in cash and $280 million in debt, and liquidity exceeding $410 million.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.